Inspira Technologies

Contributing Author

Recent Articles by Inspira Technologies

Feb-05	Inspira Announces Pricing of $4.75 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules IINN -6.49% GlobeNewswire
Feb-03	Inspira Technologies Validates Next-Gen Standalone HYLA Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market IINN GlobeNewswire
Jan-29	ART100 Becomes Inspira's First System to Complete Clinical Evaluation and Enters Budgeted Procurement at Top U.S. Medical Center IINN GlobeNewswire
Jan-21	Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders IINN GlobeNewswire
Jan-08	Inspira Outlines Strategic Vision and Transaction Framework for Breast Cancer Liquid Biopsy Expansion IINN GlobeNewswire
Jan-05	CORRECTION - Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation IINN +7.76% GlobeNewswire
Jan-05	Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation IINN +7.76% GlobeNewswire
Dec-23	Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones IINN GlobeNewswire
Dec-15	Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution IINN -8.70% GlobeNewswire
Dec-09	Inspira Technologies Granted Patent in Japan for the INSPIRA ART System's Convertible Dual Lumen Cannula Device and Method of Use IINN GlobeNewswire
Dec-03	Inspira Technologies Announces Strategic Leap in Lab Capabilities - Accelerating Next-Generation Diagnostics and Blood Technology IINN -6.96% GlobeNewswire
Nov-13	Inspira Completes Clinical Study for HYLA Blood Sensor - Ahead of Regulatory Submission IINN GlobeNewswire
Nov-06	Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion IINN +15.63% GlobeNewswire
Oct-22	Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira's Global Ecosystem IINN -7.96% GlobeNewswire
Oct-21	Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm IINN GlobeNewswire
Oct-21	Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm IINN GlobeNewswire
Oct-01	Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update IINN -6.30% GlobeNewswire
Sep-18	Inspira to Unveil HYLA Real-Time Blood Sensor at U.S. ELSO; 97.35% Accuracy Confirmed IINN +6.84% GlobeNewswire
Sep-11	Inspira Announces 97.3% Accuracy Results for HYLA Blood Sensor, Advancing Toward FDA Submission for Clearance IINN -7.20% GlobeNewswire
Sep-02	Top U.S. Honor Roll Hospital Expands Use of INSPIRA ART100 System to Lung Transplant Procedures IINN GlobeNewswire
Aug-22	Inspira Receives U.S. Patent Approval for the ART500 Core Technology, Key Patent Positions the Company to Dominate $20 Billion Estimated Market IINN -6.40% GlobeNewswire
Aug-19	Inspira Secures $27 Million Government Binding Purchase Order for ART100 Systems with Full Payment in 2025 IINN GlobeNewswire
Aug-07	Inspira Clarifies Routine Nature of Registration Statement on Form F-3 Filing Performed Every Three Years IINN GlobeNewswire
Jul-31	Inspira Activates U.S. Based Consulting Firm to Execute Transformational Initiatives IINN GlobeNewswire
Jul-18	Inspira Regains Compliance with Nasdaq Minimum Bid Price Requirement IINN GlobeNewswire
Jul-10	Inspira Achieves All Key Objectives in Previously Announced Government Talks, Forging a Pathway to National Adoption and Global Scale-Up of the ART100 IINN GlobeNewswire
Jul-07	Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework IINN +29.41% GlobeNewswire
Jul-02	Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase IINN +32.71% GlobeNewswire
Jun-11	Inspira's ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions IINN +13.79% GlobeNewswire
Jun-05	CORRECTION - Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority IINN +25.21% GlobeNewswire
Jun-05	Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority IINN +25.21% GlobeNewswire
May-29	Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System IINN +25.65% GlobeNewswire
May-27	Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives IINN -7.05% GlobeNewswire
May-07	INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients IINN -8.10% GlobeNewswire

Inspira Technologies

Recent Articles by Inspira Technologies

Upgrade your FINVIZ experience